Navigation Links
CABI helps phase out dangerous pesticide in EU
Date:9/12/2007

Methyl bromide is a highly toxic fumigant pesticide which is injected into soil to sterilise it before planting crops. It is also used as a post-harvest decontaminant of products and storage areas. Although it is highly effective in eradicating pests such as nematodes, weeds, insects and rodents, it depletes the ozone layer and poses a danger to human health.

The "Partners Award" forms part of the 20th anniversary of the Montreal Protocol - an agreement signed by more than 180 countries in 1987 - in a bid to stop the use of controlled ozone depleting substances.

It will be presented to CABI for identifying and documenting alternatives to replace methyl bromide, for implementing a system to transparently assess requests for its critical use and for supporting the development of a methyl bromide phase-out management strategy.

Methyl bromide was listed under the Montreal Protocol as a potentially dangerous pesticide. Dr Janny Vos, CABIs leading pesticide alternatives scientist, explains:

In the 1970s and 80s, growing evidence suggested that methyl bromide could cause damage to both the ozone layer and human health. Scientists found that occupational exposure to the substance could be linked to cancer. As a result, methyl bromide was banned under the Montreal Protocol in 1992.

All industrialised countries were asked to consent to phase out methyl bromide use by January 1st 2005. Developing countries were given until 2015.

However, although alternatives were found for more than 93% of the uses of methyl bromide, many countries claimed that because of regulatory restrictions, availability, cost and local conditions, they had little choice but to continue its use as a pest control. As a result they sought exemption for so-called critical use of methyl bromide from the protocol.

In order to help reduce the number of exemptions being awarded in the EU, CABI and its partners worked with the European Commission to develop and implement a system to assess requests for the critical use of methyl bromide, based on the Montreal Protocol as well as additional EC regulation.

CABI also looked at alternative practises around the globe, especially in countries that have similar climatic conditions to those requesting the continual use of methyl bromide. They presented countries with alternatives such as fumigants and chemicals, biocontrols and physical practices such as solarisation and steam treatment of the soil.

On CABIs collaboration with the European Commission, Dr Vos said:

We are extremely proud of the joint efforts of CABI and the European Commission to significantly reduce the usage of this Methyl Bromide in the EU. Our work will help set the precedence for reducing the use of methyl bromide in other parts of the world, and also for reducing reliance on other hazardous pesticides in the future.

Thanks to CABIs work, results have been impressive. In 2005, 5.7 million kg of methyl bromide was requested for critical usage by EU member states. In 2007 only 0.5 million kg was approved to five EU countries, with a majority of these pledging total elimination by 2008.


'/>"/>

Contact: Lynsey Sterrey
l.sterrey@cabi.org
44-149-182-9361
CABI
Source:Eurekalert

Related biology news :

1. Jumping gene helps explain immune systems abilities
2. Protein helps regulate the genes of embryonic stem cells
3. Scientists reveal the shape of a protein that helps retroviruses break into cells
4. Thai spice helps cut blood sugar swings
5. Newly Discovered Branding Process Helps Immune System Cells Pick Their Fights
6. Chemists synthesize molecule that helps body battle cancers, malaria
7. Ancient DNA helps clarify the origins of two extinct New World horse species
8. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
9. Study: Well-known protein helps stem cells become secretory cells
10. Beyond genes: Lipid helps cell wall protein fold into proper shape
11. Simple sea sponge helps scientists understand tissue rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... -- Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the US, ... World. Annual estimates and forecasts are provided for the period 2015 ... markets. Market data and analytics are derived from primary and secondary ...
(Date:2/17/2017)... Mass. , Feb. 17, 2017  If ... small tumor had a mutation-conferring resistance to chemotherapy, ... Recently, genomics research has focused on finding these ... or even from circulating tumor DNA in blood ... new oncology therapeutics. Unfortunately, however, detecting ...
(Date:2/16/2017)... ... February 16, 2017 , ... EIT Digital has launched work to ... industry. Pilot studies are about to get under way for the framework, which is ... innovations. The concept is expected to be transferred eventually to other industries that also ...
(Date:2/16/2017)... PARK, Calif. and GREENWICH, ... Capital, a private investment firm focused on venture ... announced the promotion of Josh Richardson , ... focuses on investments in biotechnology companies.  He is ... has played important roles in Longitude,s investments in ...
Breaking Biology Technology: